In vitro gene amplification for prenatal diagnosis of congenital adrenal hyperplasia.

AUTOR(ES)

Rumsby, G

RESUMO

A simple, rapid, non-radioactive method for detecting homozygous deletions/conversions of the steroid 21-hydroxylase gene is described. In our experience this method will be useful for first trimester prenatal diagnosis of congenital adrenal hyperplasia in 17% of families of a child with the salt losing form. This test includes an internal control to monitor the success of amplification.

Documentos Relacionados

• Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia.
• Gene conversion-like events cause steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.
• Prenatal diagnosis of congenital adrenal hyperplasia: reliability of amniotic fluid steroid analysis.
• P450XXI (steroid 21-hydroxylase) gene deletions are not found in family studies of congenital adrenal hyperplasia.
• Deletion of the steroid 21-hydroxylase and complement C4 genes in congenital adrenal hyperplasia.